drugset / Trial / NCT00212368

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

NCT00212368

Phase 3 Completed Nobelpharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Timeline

Start
2004-10
Primary completion
2005-08
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown

Indications